Other diseases of gallbladder

K11_GALLBLAOTH

gallbladder disease: A disease involving the gall bladder.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K82 Hospital discharge: ICD-9 — 575[3-9] Hospital discharge: ICD-8 — 57600\|57602\|57604 Cause of death: ICD-10 — K82 Cause of death: ICD-9 — 575[3-9] Cause of death: ICD-8 — 57600\|57602\|57604 2 out of 7 registries used, show all original rules.	1717
4. Check minimum number of events None	1717
5. Include endpoints None	1717
6. Filter based on genotype QC (FinnGen only)	1717

Control definitions (FinnGen only)

Control exclude: K11_GALLBILPANC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K80-K87
Name in latin: Alii morbi vesicae biliaris

NAME	K11_GALLBLAOTH
CONTROL_EXCLUDE	K11_GALLBILPANC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K82
HD_ICD_9	575[3-9]
HD_ICD_8	57600\|57602\|57604
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K82
COD_ICD_9	575[3-9]
COD_ICD_8	57600\|57602\|57604
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other diseases of gallbladder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	14816	9612	5039
Only index persons	11458	7755	3703
Unadjusted period prevalence (%)
Whole population	0.23	0.28	0.14
Only index persons	0.24	0.29	0.14
Median age at first event (years)
Whole population	53.44	50.94	58.14
Only index persons	50.54	48.38	55.05

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1717	1088	629
Unadjusted period prevalence (%)	0.34	0.37	0.28
Median age at first event (years)	49.72	45.48	57.06

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1535: Matched controls
15348

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

173.1

323.0

359

57600

ICD-8 Finland

Other diseases of gallbladder and biliary, Cholesterosis vesicae felleae

+∞

323.0

344

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

965.3

323.0

517

K82.8

ICD-10 Finland

Other specified diseases of gallbladder

3072.5

286.5

268

K82.9

ICD-10 Finland

Disease of gallbladder, unspecified

2588.0

247.6

233

K82.4

ICD-10 Finland

Cholesterolosis of gallbladder

+∞

209.2

196

K82.2

ICD-10 Finland

Perforation of gallbladder

+∞

162.4

153

5756A

ICD-9 Finland

Other disorders of gallbladder, Cholesterolosis of gallbladder

+∞

159.2

150

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

+∞

123.6

117

JKA20

NOMESCO Finland

Cholecystectomy

50.4

114.2

138

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.5

108.3

719

3082

6662

FHL

Cholecystectomy

554.7

106.0

104

6663

FHL

Cholecystectomy and cholangiography

441.0

84.9

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

142.3

76.7

K82.0

ICD-10 Finland

Obstruction of gallbladder

+∞

75.6

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.8

73.7

363

1155

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

32.9

68.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

5.2

63.9

215

467

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

+∞

58.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

55.9

569

2878

5759X

ICD-9 Finland

Other disorders of gallbladder, Unspecified disorder of gallbladder

+∞

53.4

UJK02

NOMESCO Finland

ERCP

30.0

51.4

K81.0

ICD-10 Finland

Acute cholecystitis

172.1

48.1

57409

ICD-8 Finland

Cholelithiasis, Unspecified

+∞

47.1

K83.0

ICD-10 Finland

Cholangitis

471.4

46.5

A02BC05

ATC

esomeprazole; systemic

2.2

45.1

704

4275

K85

ICD-10 Finland

Acute pancreatitis

123.7

45.0

A02BC02

ATC

pantoprazole; systemic

2.1

41.8

1045

7668

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.4

40.7

223

740

N02AX02

ATC

tramadol; systemic, rectal

2.1

40.2

698

4369

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.1

40.0

252

927

5742A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

+∞

39.7

K81.9

ICD-10 Finland

Cholecystitis, unspecified

397.1

39.2

5758X

ICD-9 Finland

Other disorders of gallbladder, Other specified disorders of gallbladder

+∞

38.7

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

194.6

36.9

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

38.6

35.7

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

10.3

34.0

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.6

33.9

290

1275

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

44.4

31.9

K83.1

ICD-10 Finland

Obstruction of bile duct

168.4

31.8

A02BC03

ATC

lansoprazole; oral

2.0

30.8

509

3030

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

52.6

30.4

K80.8

ICD-10 Finland

Other cholelithiasis

52.6

30.4

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

+∞

30.3

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

29.9

447

2552

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

29.3

464

2705

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

+∞

29.3

A02BA02

ATC

ranitidine; systemic

2.2

29.1

368

1952

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

25.6

28.9

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

28.8

428

2429

JN3AD

NOMESCO Finland

Abdominal CT examination

3.4

28.1

144

452

UJF32

NOMESCO Finland

Coloscopy

2.0

27.5

443

2589

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

26.8

689

4751

K82.3

ICD-10 Finland

Fistula of gallbladder

+∞

25.1

A02BC01

ATC

omeprazole; systemic

1.9

24.5

465

2867

J01MA02

ATC

ciprofloxacin; systemic

1.8

24.0

610

4139

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

23.4

314

1688

TJK01

NOMESCO Finland

Laparoscopic cholangiography

+∞

23.0

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

+∞

21.9

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

29.5

21.9

P01AB01

ATC

metronidazole; oral, rectal

1.7

20.3

590

4113

K30

ICD-10 Finland

Functional dyspepsia

2.4

19.9

179

794

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

19.6

297

1666

R03AC02

ATC

salbutamol; inhalant

1.6

19.5

746

5596

N03AX16

ATC

pregabalin; oral

1.8

19.2

371

2268

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

+∞

18.8

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.1

18.7

107

363

N02BE01

ATC

paracetamol; systemic, rectal

1.8

18.2

1279

11249

K85.8

ICD-10 Finland

Other acute pancreatitis

+∞

17.7

K82.1

ICD-10 Finland

Hydrops of gallbladder

+∞

17.7

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

181.9

17.5

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

8.4

17.5

WX402

NOMESCO Finland

General anaesthesia

2.0

17.3

232

1236

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

17.1

318

1907

A05AA02

ATC

ursodeoxycholic acid; oral

8.1

17.1

J01DB01

ATC

cefalexin; oral

1.7

16.8

1172

10101

H02AB06

ATC

prednisolone; systemic

1.6

16.6

685

5162

M79.6

ICD-10 Finland

Pain in limb

1.6

16.5

519

3642

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

+∞

15.6

D06

ICPC

Abdominal pain localized other

2.5

15.1

124

523

WX002

NOMESCO Finland

Sedation and analgesia

1.8

15.1

310

1915

D02

ICPC

Abdominal pain epigastric

3.1

15.0

271

A03FA02

ATC

cisapride; oral, rectal

2.3

15.0

148

688

R10.0

ICD-10 Finland

Acute abdomen

4.2

15.0

140

5754A

ICD-9 Finland

Other disorders of gallbladder, Perforation of gallbladder

+∞

14.6

57401

ICD-8 Finland

Cholelithiasis, Cum cholecystitide chronica

+∞

14.6

TJK00

NOMESCO Finland

Intraoperative cholangiography

80.9

14.6

D01

ICPC

Abdominal pain/cramps general

2.2

14.5

147

692

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

14.5

878

7159

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

14.4

268

1599

A03CA02

ATC

clidinium and psycholeptics; oral

2.5

14.4

114

473

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

14.6

14.1

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

13.9

358

2359

JAH01

NOMESCO Finland

Laparoscopy

3.2

13.9

230

J01MA12

ATC

levofloxacin; systemic

1.8

13.8

272

1654

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

13.7

174

901

K86.1

ICD-10 Finland

Other chronic pancreatitis

+∞

13.6

57408

ICD-8 Finland

Cholelithiasis, Alia definita

+∞

13.6

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

13.5

152

750

J01DA01

ATC

[U] cefalexin; systemic

1.5

13.5

895

7387

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

13.3

516

3771

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

13.2

158

797

M03BX02

ATC

tizanidine; oral

1.5

13.2

828

6735

M25.5

ICD-10 Finland

Pain in joint

1.6

13.2

380

2577

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

13.2

217

1241

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

13.1

554

4133

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

13.1

140

677

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

13.0

294

H02AB04

ATC

methylprednisolone; systemic

1.9

12.9

217

1251

C07AB07

ATC

bisoprolol; oral

1.5

12.9

711

5616

A09AA02

ATC

multienzymes (lipase, protease etc.)

8.1

12.8

R4110

NOMESCO Finland

Physiotherapy

1.6

12.8

384

2633

M54.5

ICD-10 Finland

Low back pain

1.6

12.7

444

3162

UJK12

NOMESCO Finland

Peroral cholangioscopy

70.4

12.6

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

12.5

253

1545

C03CA01

ATC

furosemide; systemic

1.6

12.5

465

3356

M01AH05

ATC

etoricoxib; oral

1.5

12.5

783

6338

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

131.0

12.4

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

131.0

12.4

K80

ICD-10 Finland

Cholelithiasis

13.3

12.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

12.3

284

1809

D98

ICPC

Cholecystitis/cholelithiasis

26.9

12.0

R53

ICD-10 Finland

Malaise and fatigue

1.7

12.0

300

1950

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

11.8

164

880

B01AB05

ATC

enoxaparin; parenteral

1.5

11.7

431

3094

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

11.6

207

1215

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

11.5

238

1466

J01FA06

ATC

roxithromycin; oral

1.5

11.5

578

4445

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

11.4

286

1856

R51.80

ICD-10 Finland

Headache

1.8

11.3

188

1077

C01DA14

ATC

isosorbide mononitrate; oral

1.7

11.3

252

1586

J45

ICD-10 Finland

Asthma

2.0

11.3

144

750

M01AH01

ATC

celecoxib; oral (coxibs)

1.7

11.2

265

1694

J01FA09

ATC

clarithromycin; systemic

1.5

11.2

418

3005

J02AC01

ATC

fluconazole; systemic

1.5

11.1

543

4141

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

11.0

162

890

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

11.0

352

2441

R96

ICPC

Asthma

2.0

10.9

135

693

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

10.8

273

1776

R01AD09

ATC

mometasone; nasal

1.5

10.8

585

4547

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

10.7

193

1138

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.8

10.6

262

M48.0

ICD-10 Finland

Spinal stenosis

1.8

10.5

193

1139

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

10.5

272

1782

D13.5

ICD-10 Finland

Benign neoplasm: Extrahepatic bile ducts

110.7

10.4

5741A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with other cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE CHR,SINE OBS]

+∞

10.4

5740A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with acute cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE AC,SINE OBST]

+∞

10.4

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

6.4

10.3

A02BA04

ATC

nizatidine; systemic

2.0

10.3

133

695

R06.0

ICD-10 Finland

Dyspnoea

1.5

10.3

353

2479

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.0

10.3

193

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

10.3

206

1254

R03DC03

ATC

montelukast; oral

1.7

10.3

209

1278

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

10.1

223

1396

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

9.9

217

1352

R07.3

ICD-10 Finland

Other chest pain

2.0

9.9

135

719

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

9.8

356

2534

A02BC04

ATC

rabeprazole; oral

2.0

9.7

120

615

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

9.7

513

3949

M01AE02

ATC

naproxen; oral, rectal

1.4

9.7

734

6046

J01AA02

ATC

doxycycline; systemic

1.5

9.6

1124

10021

J01FA10

ATC

azithromycin; systemic

1.4

9.6

738

6089

AA1AD

NOMESCO Finland

CT of head and brain

1.5

9.6

341

2412

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

3.1

9.6

174

R13

ICD-10 Finland

Dysphagia

2.2

9.6

101

485

G47.3

ICD-10 Finland

Sleep apnoea

1.6

9.5

257

1699

K29.7

ICD-10 Finland

Gastritis, unspecified

2.8

9.5

221

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

9.5

186

1125

K86.2

ICD-10 Finland

Cyst of pancreas

100.6

9.4

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

9.4

302

2084

57500

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Cholecystitis acuta

+∞

9.4

57609

ICD-8 Finland

Other diseases of gallbladder and biliary, Alii definiti sive NUD

+∞

9.4

5770A

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]

+∞

9.4

K82

ICD-10 Finland

Other diseases of gallbladder

+∞

9.4

K81.1

ICD-10 Finland

Chronic cholecystitis

+∞

9.4

N05BA01

ATC

diazepam; systemic, rectal

1.7

9.3

196

1210

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

9.2

645

5216

M01AH02

ATC

rofecoxib; oral

1.7

9.2

201

1255

UJD02

NOMESCO Finland

Gastroscopy

2.4

9.2

338

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.9

9.1

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

9.1

360

2602

M02AA07

ATC

piroxicam; topical

1.4

9.1

534

4182

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

9.0

138

771

N03AX12

ATC

gabapentin; oral

1.7

9.0

211

1345

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

8.9

320

2263

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

8.8

310

2183

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

8.8

424

3190

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

8.7

390

ZXA05

NOMESCO Finland

Left side

1.5

8.6

374

2754

WX110

NOMESCO Finland

Local anesthesy

1.4

8.6

891

7683

M01AX17

ATC

nimesulide; oral

1.5

8.6

350

2545

A03DA02

ATC

pitofenone and analgesics; systemic

3.3

8.5

127

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

8.5

111

586

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

8.4

279

1934

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.1

8.3

57708

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta alia

+∞

8.3

57608

ICD-8 Finland

Other diseases of gallbladder and biliary, Dyskinesia viarum biliferarum

+∞

8.3

JKB00

NOMESCO Finland

Incision of bile duct

+∞

8.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

8.3

599

4847

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

8.2

242

1629

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

8.2

106

556

R05

ICD-10 Finland

Cough

1.6

8.1

252

1721

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

8.1

141

820

L04AX01

ATC

azathioprine; systemic

2.5

8.1

245

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.9

8.1

N06AX21

ATC

duloxetine; oral

1.8

8.1

134

769

I20.09

ICD-10 Finland

Unstable angina

2.1

8.0

418

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

8.0

356

2630

J01CA04

ATC

amoxicillin; systemic

1.4

7.9

1086

9746

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.6

7.9

216

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.7

7.9

192

J01EA01

ATC

trimethoprim; systemic

1.4

7.8

370

2768

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

7.7

227

1530

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

7.7

476

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

45.2

7.7

M54.3

ICD-10 Finland

Sciatica

2.1

7.7

390

M01AB55

ATC

diclofenac, combinations; oral

1.9

7.7

105

563

R03BA02

ATC

budesonide; inhalant

1.6

7.7

235

1600

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

7.7

334

2453

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

7.6

298

2140

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

6.7

7.6

R01AD08

ATC

fluticasone; nasal

1.4

7.6

357

2664

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

25.1

7.6

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.2

7.6

361

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.7

7.5

178

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.7

7.5

186

R03AC03

ATC

terbutaline; inhalant

1.6

7.5

186

1199

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.1

7.5

389

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

7.5

344

2555

J01MA01

ATC

ofloxacin; systemic

1.8

7.5

127

735

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

7.4

118

667

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

7.4

649

5388

ZXA10

NOMESCO Finland

Bilateral

1.5

7.4

265

1868

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

7.4

396

A11

ICPC

Chest pain NOS

1.9

7.4

110

610

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

7.3

129

753

L17

ICPC

Foot/toe symptom/complaint

1.4

7.3

337

2502

57709

ICD-8 Finland

Diseases of pancreas, Pancreatitis NUD

+∞

7.3

5750A

ICD-9 Finland

Other disorders of gallbladder, Acute cholecystitis

+∞

7.3

5745A

ICD-9 Finland

Cholelithiasis, Calculus of bile duct without mention of cholecystitis[CHOLEDOCHOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

+∞

7.3

K85.1

ICD-10 Finland

Biliary acute pancreatitis

+∞

7.3

R05

ICPC

Cough

1.5

7.3

277

1977

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

7.3

220

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

7.2

282

2025

R42

ICD-10 Finland

Dizziness and giddiness

1.5

7.2

299

2174

XKC03

NOMESCO Finland

Water cystometry

2.6

7.2

197

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

7.2

126

735

A02BA03

ATC

famotidine; systemic

2.2

7.2

315

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

7.1

683

5744

R21

ICPC

Throat symptom/complaint

1.6

7.1

200

1332

R06AE07

ATC

cetirizine; oral

1.4

7.1

557

4540

A02BDXX

ATC

2.4

7.1

244

J01DA06

ATC

[U] cefuroxime; systemic

1.6

7.1

201

1342

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

5.3

7.1

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.3

7.1

276

C08CA05

ATC

nifedipine; systemic

1.9

7.1

100

544

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

7.1

303

2216

N06AA09

ATC

amitriptyline; systemic

1.7

7.0

138

834

C08CA01

ATC

amlodipine; oral

1.4

7.0

496

3975

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

7.0

240

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

6.9

339

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

6.9

591

4876

R02

ICPC

Shortness of breath/dyspnoea

1.6

6.9

160

1012

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.8

6.9

148

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

6.9

882

7731

K76.9

ICD-10 Finland

Liver disease, unspecified

3.7

6.9

R03BA01

ATC

beclometasone; inhalant

1.6

6.9

193

1288

A46

ICD-10 Finland

Erysipelas

1.6

6.9

184

1213

Y0599

ICD-8 Finland

Investigation of digestive system

3.4

6.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

6.8

116

675

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

22.6

6.7

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

6.6

177

1162

1413

FHL

Laparoscopy and other therapeutic procedure

2.8

6.6

140

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.5

6.6

R12

ICD-10 Finland

Heartburn

1.9

6.6

496

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.0

6.6

118

JAH00

NOMESCO Finland

Laparotomy

2.7

6.6

164

R74

ICPC

Upper respiratory infection acute

1.4

6.5

294

2167

J20

ICD-10 Finland

Acute bronchitis

1.7

6.5

124

742

J01FA15

ATC

telithromycin; oral

1.7

6.5

124

745

N05CF01

ATC

zopiclone; oral

1.4

6.5

453

3610

R60.0

ICD-10 Finland

Localized oedema

1.6

6.5

151

958

R11

ICD-10 Finland

Nausea and vomiting

1.8

6.4

104

593

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

70.1

6.4

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

70.1

6.4

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

6.4

583

4837

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

6.4

100

562

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

6.4

534

K11.2

ICD-10 Finland

Sialoadenitis

2.7

6.4

154

UKC02

NOMESCO Finland

Cystoscopy

1.5

6.4

210

1452

K76.80

ICD-10 Finland

Hepatic cyst

6.0

6.3

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

6.3

230

1626

C10AC01

ATC

colestyramine; oral

2.9

6.3

126

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

18.1

6.3

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

18.1

6.3

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

6.3

108

630

JK1AT

NOMESCO Finland

Cathetrisation of bile cyst with radiological guidance

+∞

6.3

K83.4

ICD-10 Finland

Spasm of sphincter of Oddi

+∞

6.3

JK3MB

NOMESCO Finland

Postoperative cholangiography

+∞

6.3

57501

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Cholecystitis chronica

+∞

6.3

JL5CM

NOMESCO Finland

Bile and pancreas ducts extensive MRI examination with 3 Tesla magnet

+∞

6.3

N02AA05

ATC

oxycodone; systemic

1.5

6.2

203

1401

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

6.2

538

L03

ICPC

Low back symptom/complaint

1.4

6.2

297

2218

A06AD11

ATC

lactulose; oral

1.5

6.2

208

1445

G44.2

ICD-10 Finland

Tension-type headache

1.6

6.2

160

1045

ZXA00

NOMESCO Finland

Right side

1.4

6.1

379

2958

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.1

6.1

339

M79.1

ICD-10 Finland

Myalgia

1.6

6.1

158

1031

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

6.1

222

1567

H02AB07

ATC

prednisone; oral

1.5

6.0

198

1368

U01

ICPC

Dysuria/painful urination

1.8

6.0

539

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

363

1283

3.32

80.62

3.7

2.2

umol/l

8.4

7.2

0.48

330

1108

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

741

3907

2.58

77.19

3.5

2.1

u/l

61.3

56.2

0.61

698

3556

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1088

6977

2.53

72.77

7.8

5.5

umol/l

11.9

11.1

1.40

1049

6588

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

312

1114

3.20

67.26

3.1

1.8

u/l

44.3

33.0

0.40

276

947

(3033658) Prothrombin time (PT) actual/Normal

597

3395

2.16

46.81

5.7

3.5

88.0

89.0

0.41

583

3298

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1344

10580

2.25

41.52

10.1

6.9

u/l

84.7

76.6

4.51

1293

9847

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

653

4026

2.00

39.74

4.2

2.9

u/l

35.4

32.0

0.71

630

3813

(3032080) INR in Blood by Coagulation assay

814

5633

1.85

33.19

11.1

9.4

inr

1.2

1.3

0.91

229

1557

(3002256) Pathology report gross observation

324

1662

2.17

31.39

1.3

—

(40768797) Stomach Pathology biopsy report

342

1828

2.09

29.62

1.3

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

253

1215

2.27

28.66

2.7

1.8

g/l

0.2

0.60

241

1119

(3048689) Calprotectin [Mass/mass] in Stool

281

1414

2.18

28.36

2.2

2.1

ug/g

163.8

125.7

0.77

219

1099

(3013115) Eosinophils [#/volume] in Blood

923

6882

1.74

27.17

6.5

5.7

e9/l

0.2

1.03

802

5964

(3006315) Basophils [#/volume] in Blood

897

6649

1.73

26.84

6.3

5.5

e9/l

0.0

0.53

764

5673

(3001604) Monocytes [#/volume] in Blood

894

6625

1.73

26.74

6.2

5.5

e9/l

0.6

1.00

758

5630

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

127

453

2.95

26.57

3.8

2.9

u/ml

81.0

2978.7

0.71

105

384

(3019198) Lymphocytes [#/volume] in Blood

911

6796

1.73

26.51

6.4

5.6

e9/l

2.0

1.9

0.65

788

5903

(3022096) Basophils/100 leukocytes in Blood

830

6049

1.72

26.18

6.6

5.7

0.7

0.29

775

5602

(3023368) Bacteria identified in Blood by Culture

569

3756

1.77

25.35

5.2

4.0

—

(3019069) Monocytes/100 leukocytes in Blood

846

6234

1.70

25.32

6.9

6.0

8.5

8.8

1.43

791

5784

(3006504) Eosinophils/100 leukocytes in Blood

843

6212

1.70

25.18

6.6

5.7

2.8

0.04

785

5747

(3002030) Lymphocytes/100 leukocytes in Blood

861

6382

1.70

25.15

6.7

5.9

27.8

27.3

0.73

799

5892

(3013650) Neutrophils [#/volume] in Blood by Automated count

1005

7783

1.70

24.77

9.1

8.7

e9/l

4.4

4.1

2.67

879

6749

(3000570) Elastase.pancreatic [Mass/mass] in Stool

303

3.30

24.72

1.4

1.3

ug/g

305.7

311.6

0.09

168

(3024561) Albumin [Mass/volume] in Serum or Plasma

828

6110

1.69

24.30

6.0

4.3

g/l

35.0

35.3

0.73

768

5623

(3013826) Glucose [Moles/volume] in Serum or Plasma

1029

8058

1.69

23.96

6.1

4.3

mmol/l

6.8

6.7

1.10

978

7525

(3018010) Neutrophils/100 leukocytes in Blood

844

6281

1.68

23.82

6.5

5.6

57.7

57.6

0.06

786

5836

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

150

4.25

23.46

2.8

2.3

u/ml

7.1

36.0

0.58

145

(36304419) Bacteria [Presence] in Urine

554

3711

1.73

22.98

3.9

3.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1136

9184

1.70

22.97

6.0

4.7

e6/l

71.6

3335.6

3.19

130

(3002582) Erythrocytes [#/volume] in Urine

602

4143

1.70

22.51

3.9

3.2

e6/l

48.1

87.3

1.04

479

3186

(3030467) Casts [#/volume] in Urine by Automated count

561

3810

1.70

21.91

3.9

3.1

e6/l

0.5

0.10

445

2889

(3024980) IgG subclass 4 [Mass/volume] in Serum

138

4.24

21.56

1.5

1.6

g/l

0.7

0.8

0.49

115

(3018095) Leukocytes [#/volume] in Urine

678

4858

1.65

21.47

4.6

3.6

e6/l

89.5

116.9

0.56

505

3436

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

314

1807

1.90

21.41

2.5

21.4

22.0

0.31

271

1531

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

921

7142

1.63

21.08

7.8

6.3

mmol/l

1.2

0.36

796

5982

(3007566) Smooth muscle Ab [Titer] in Serum

297

3.11

20.91

1.4

1.1

titre

141.0

74.1

—

(3022145) Colonoscopy Study observation

261

1428

1.98

20.62

1.4

1.3

—

(3026782) Osmolality of Urine

426

2720

1.75

20.58

3.2

2.7

mosm/kgh2o

526.2

535.1

0.37

373

2301

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

197

973

2.16

20.53

1.7

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

729

5366

1.62

20.44

4.5

3.7

ng/l

106.1

47.0

0.40

521

3846

(3022948) Iron [Moles/volume] in Serum or Plasma

352

2131

1.82

20.35

2.4

umol/l

12.6

12.7

0.05

329

1965

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1026

8210

1.62

20.32

4.5

2.9

u/l

58.7

44.7

3.64

956

7524

(3004789) Transferrin [Mass/volume] in Serum or Plasma

327

1946

1.84

19.95

2.5

2.4

g/l

2.4

2.3

1.37

312

1799

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

257

1415

1.96

19.90

3.6

4.1

ug/l

11.0

22.4

0.79

201

1167

(3037467) Urinalysis macro (dipstick) panel - Urine

1146

9452

1.64

19.81

5.4

4.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

183

893

2.17

19.64

2.4

2.8

g/l

10.9

10.6

0.22

172

806

(3000850) Epithelial cells [#/volume] in Urine

445

2914

1.71

19.49

3.1

2.5

e6/l

4.7

6.0

2.08

395

2547

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

419

2713

1.72

19.06

4.3

3.7

ng/l

292.6

345.5

0.19

333

2210

(3028026) IgM [Mass/volume] in Serum or Plasma

153

704

2.29

18.93

1.7

1.8

g/l

1.6

0.07

144

637

(42870588) Differential panel, method unspecified - Blood

635

4594

1.61

18.66

6.4

5.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

369

2318

1.75

18.65

1.5

1.4

g/l

2.5

2.4

0.12

222

1335

(3013707) Erythrocyte sedimentation rate by Westergren method

1202

10124

1.63

18.18

5.0

4.1

mm/h

13.5

13.1

0.41

1112

9299

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

843

6549

1.56

18.03

7.4

5.5

mmol/l

1.2

0.87

778

5852

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

349

2182

1.75

17.86

3.2

2.9

e6/l

2.8

2.5

0.16

184

1204

(3044640) Blood type and Crossmatch panel - Blood

598

4304

1.60

17.74

2.8

2.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

366

2327

1.73

17.62

3.2

2.7

e6/l

1.1

1.3

0.30

202

1339

(40758558) Short blood count panel - Blood

498

3458

1.62

17.01

6.8

6.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

740

5646

1.55

16.74

3.1

2.7

ug/l

129.6

128.9

0.02

693

5129

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

233

3.09

16.54

2.7

3.2

u/ml

367.1

1661.5

0.58

214

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

804

6263

1.53

16.44

4.6

3.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

4.88

16.40

1.6

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1492

13429

1.85

16.36

22.1

14.2

mg/l

24.3

24.5

0.08

1293

10553

(3009261) Glucose [Presence] in Urine by Test strip

844

6679

1.52

15.81

4.9

3.9

estimate

0.0

0.80

149

1180

(3000991) Gas panel - Venous blood

202

1115

1.92

15.36

9.0

7.4

—

(3035350) Ketones [Presence] in Urine by Test strip

830

6579

1.51

15.21

4.8

3.8

estimate

0.0

0.00

148

1193

(3021601) Nitrite [Presence] in Urine by Test strip

831

6613

1.50

14.79

6.4

5.1

estimate

0.0

0.50

150

1191

(3013139) Helicobacter pylori Ag [Presence] in Stool

163

847

2.02

14.74

1.2

1.3

—

(3021589) Normoblasts [#/volume] in Blood

751

5872

1.50

14.46

11.4

9.4

e9/l

0.0

0.51

595

4762

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

418

2887

1.59

14.20

2.2

1.7

mg/l

1.1

1.3

1.01

327

2225

(3012095) Magnesium [Moles/volume] in Serum or Plasma

337

2218

1.65

13.91

3.6

3.0

mmol/l

0.8

1.97

318

2042

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

462

3282

1.56

13.84

2.7

2.2

—

(3037522) Nuclear Ab [Titer] in Serum

266

1666

1.71

13.22

1.4

1.3

titre

347.5

528.4

1.81

362

(3026008) Bacteria identified in Urine by Culture

598

4545

1.48

12.83

3.9

3.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

493

3602

1.52

12.82

2.6

2.2

mg/l

3.0

0.05

423

3009

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

759

6052

1.46

12.69

2.2

2.0

pmol/l

97.4

96.3

0.24

405

2926

(3003458) Phosphate [Moles/volume] in Serum or Plasma

277

1773

1.67

12.65

6.1

5.0

mmol/l

1.0

0.43

248

1621

(3018418) pH of Serum or Plasma

576

4357

1.48

12.61

4.7

3.8

7.4

0.88

779

(3025941) Bacteria identified in Stool by Culture

132

675

2.04

12.46

1.4

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

3.95

12.29

1.3

1.1

titre

170.0

75.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

5.16

12.22

1.2

1.0

—

(3044889) 12 lead EKG panel

1132

9772

1.47

12.18

4.5

3.9

—

(3052851) Hemolysis interference index of Serum or Plasma

432

2.27

12.09

3.1

3.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

473

3469

1.50

11.93

2.9

2.6

umol/l

4052.7

6233.2

0.52

403

2957

(3027801) Oxygen [Partial pressure] in Arterial blood

252

1608

1.66

11.59

8.2

6.4

kpa

12.4

12.2

0.26

243

1529

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

252

1608

1.66

11.59

8.2

6.4

kpa

5.1

0.02

243

1528

(3003396) Base excess in Arterial blood by calculation

251

1602

1.66

11.53

8.3

6.4

mmol/l

1.0

1.1

0.19

202

1247

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

134

711

1.96

11.41

11.2

9.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

310

2092

1.59

11.36

2.3

2.0

29.9

29.6

0.45

303

2028

(3016502) Oxygen saturation in Arterial blood

227

1417

1.69

11.34

8.6

6.9

95.7

95.4

0.29

222

1362

(3011397) Hemoglobin [Presence] in Urine by Test strip

438

3192

1.50

11.30

4.8

3.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

190

1139

1.75

10.97

8.9

6.5

mmol/l

9.6

10.3

0.69

177

1085

(3021447) Carbon dioxide [Partial pressure] in Venous blood

202

1237

1.72

10.81

4.3

3.3

kpa

5.8

0.07

197

1201

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

377

2687

1.52

10.76

1.3

1.2

u/ml

0.9

1.6

1.34

680

(3042936) Bacteria identified in Isolate by Culture

284

1903

1.59

10.68

2.3

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

191

1157

1.73

10.63

1.5

—

(3002032) Base excess in Venous blood by calculation

200

1228

1.71

10.60

4.3

3.4

mmol/l

1.9

0.09

174

975

(3003327) Ova and parasites identified in Stool by Light microscopy

378

2.26

10.56

1.7

1.6

—

(40768804) Tissue Pathology biopsy report

692

5557

1.41

10.50

2.4

2.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1521

14119

1.68

10.47

25.0

16.9

mmol/l

4.0

2.53

1490

13693

(3019550) Sodium [Moles/volume] in Serum or Plasma

1518

14086

1.67

10.44

24.8

16.7

mmol/l

139.6

0.13

1488

13675

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

335

2349

1.53

10.27

2.2

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

1233

10981

1.44

10.01

25.8

17.6

13.9

13.8

1.49

1220

10719

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

557

4337

1.42

9.94

2.4

2.1

u/l

180.1

217.1

0.80

525

4076

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

715

5819

1.39

9.85

2.6

2.2

nmol/l

78.1

79.1

0.43

643

5105

(3020682) Albumin/Creatinine [Ratio] in Urine

547

4259

1.42

9.72

4.1

3.9

mg/mmol

6.7

8.4

0.57

319

2587

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

559

4380

1.41

9.55

3.3

3.0

ng/l

1224.3

1587.7

1.98

483

3747

(3009508) Creatinine [Moles/volume] in Urine

542

4224

1.41

9.55

3.2

3.1

mmol/l

7.4

7.0

1.09

444

3510

(3023183) Ammonium ion [Moles/volume] in Plasma

236

2.51

9.50

3.9

2.5

umol/l

33.2

33.8

0.07

200

(3007853) Bacteria identified in Skin by Aerobe culture

229

1500

1.61

9.41

2.0

1.7

—

(3012516) Albumin [Mass/volume] in Urine

522

4055

1.41

9.32

3.3

3.2

mg/l

680.7

304.6

0.69

314

2479

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

249

1674

1.57

9.16

2.2

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

208

1352

1.61

8.81

1.6

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

186

2.63

8.71

1.2

u/ml

303.7

299.9

0.03

106

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

246

1675

1.55

8.53

2.2

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

311

2228

1.48

8.47

1.3

1.2

iu/ml

23.3

39.7

2.46

712

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1171

10473

1.37

8.26

4.4

4.1

pmol/l

15.0

14.9

0.54

1078

9407

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

147

888

1.72

8.25

2.0

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

107

589

1.87

8.20

1.1

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

287

2.24

8.07

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

616

5016

1.36

7.99

5.2

4.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

128

753

1.76

7.90

10.6

8.2

mmol/l

24.5

0.01

121

696

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1360

12503

1.42

7.89

5.5

4.9

mu/l

1.9

2.1

1.02

1262

11295

(3014007) Fractional oxyhemoglobin in Arterial blood

143

869

1.70

7.86

10.1

8.0

94.5

93.9

0.60

143

863

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

867

7444

1.33

7.82

3.1

2.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

209

2.43

7.79

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

203

2.46

7.78

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

129

770

1.73

7.57

2.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

4.12

7.54

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.12

7.54

1.1

1.0

—

(3000492) Spirometry study

183

1201

1.59

7.43

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.95

7.38

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

191

2.45

7.29

1.7

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

610

5014

1.34

7.27

3.3

mmol/l

2.4

0.07

521

4323

(3019150) Specific gravity of Urine by Refractometry

382

2919

1.40

7.24

5.4

4.3

kg/l

1.0

0.08

428

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

426

1.95

7.15

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1519

14330

1.52

7.08

14.6

10.2

u/l

27.0

24.4

6.62

1475

13745

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

188

2.43

7.05

1.4

u/ml

131.8

112.3

1.00

(40761511) CBC panel - Blood by Automated count

1485

13948

1.48

7.04

19.4

13.7

—

(40768441) Liver Pathology biopsy report

3.11

7.02

1.8

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

111

649

1.76

7.02

3.5

2.3

1.2

0.13

111

644

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

3.65

6.75

1.0

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1371

12724

1.39

6.68

19.5

13.6

ml/min/173m2

77.7

77.1

0.49

1143

10488

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

255

1842

1.45

6.57

1.6

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

158

2.50

6.54

1.1

—

(3003338) MCHC [Mass/volume]

1216

11102

1.33

6.44

27.3

18.8

g/l

331.6

331.5

0.25

1206

10995

(3019060) Gas panel - Arterial blood

145

934

1.60

6.38

5.1

4.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

184

1252

1.53

6.37

2.5

2.4

ug/l

6.2

6.9

0.26

154

1077

(3029937) Albumin [Presence] in Urine by Test strip

446

3568

1.34

6.21

5.7

4.2

estimate

0.0

0.08

147

1165

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

221

2.21

6.07

8.8

5.1

iu/ml

40798.3

899.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

106

640

1.70

6.01

4.2

3.4

mmol/l

24.0

0.01

100

572

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

165

2.40

5.99

1.0

—

(4062490)

3.01

5.96

1.2

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.92

5.90

1.8

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

449

1.82

5.84

1.8

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

182

1259

1.50

5.83

2.7

2.8

ng/l

215.6

0.00

166

1146

(3009542) Hematocrit [Volume Fraction] of Blood

1301

12053

1.33

5.83

23.4

15.7

39.3

39.1

0.37

909

8165

(3042733) HLA Ab [Presence] in Serum

5.03

5.74

3.3

5.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

2.99

5.69

1.2

1.3

g/l

0.3

0.4

1.08

(3028192) IgG subclass 2 [Mass/volume] in Serum

2.99

5.69

1.2

1.3

g/l

2.5

2.9

0.73

(3027135) IgG subclass 1 [Mass/volume] in Serum

2.99

5.69

1.2

1.3

g/l

6.1

6.9

0.75

(36660697) Celiac disease serology panel - Serum

144

957

1.55

5.56

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

3.84

5.54

37.1

30.7

ug/l

113.1

117.9

0.10

(3022217) INR in Platelet poor plasma by Coagulation assay

258

1926

1.40

5.51

30.9

26.9

inr

1.4

0.12

232

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.83

5.49

1.0

—

(4010399)

145

970

1.54

5.44

1.5

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

423

3420

1.31

5.37

4.2

3.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

130

852

1.57

5.35

7.0

6.2

mmol/l

24.0

24.6

1.09

124

793

(3000494) Fungus identified in Specimen by Culture

211

1532

1.43

5.27

1.5

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

170

1192

1.47

5.11

2.3

2.7

g/l

66.0

66.1

0.09

155

1065

(3024932) HLA-DR beta [Type]

4.47

5.04

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.31

4.83

1.3

1.2

—

(3024471) HLA-A [Type]

4.31

4.83

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

394

1.78

4.81

1.3

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

120

797

1.54

4.68

1.7

1.5

—

(3036489) Thrombin time

481

1.70

4.67

2.4

1.9

22.9

21.8

0.29

436

(42529406) Shigella sp [Presence] in Stool by Culture

398

1.76

4.66

1.3

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

376

1.79

4.65

2.6

2.0

90.1

90.2

0.01

351

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

391

1.77

4.64

1.4

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

345

2766

1.31

4.59

5.2

4.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

216

1614

1.39

4.58

4.6

3.9

u/l

239.1

247.3

0.45

203

1523

(3036481) Cortisol [Moles/volume] in Serum or Plasma

169

1210

1.44

4.57

1.9

2.1

nmol/l

343.3

372.2

1.27

155

1102

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

142

2.28

4.49

1.3

1.2

nmol/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

172

1240

1.43

4.48

1.6

1.7

1.4

1.5

0.26

152

1057

(3047181) Lactate [Moles/volume] in Blood

411

1.73

4.46

7.1

5.8

mmol/l

1.4

1.3

0.36

360

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

344

1.80

4.46

1.3

—

31.1

—

(1616796) Gas panel - Central venous blood

279

1.89

4.44

5.5

3.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

308

1.85

4.43

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

308

1.85

4.43

1.5

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

109

719

1.55

4.40

1.4

1.2

u/ml

239.7

170.4

0.69

100

646

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

106

2.48

4.39

1.9

2.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

177

2.11

4.34

1.4

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.52

4.33

2.6

1.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

142

996

1.46

4.28

2.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

275

2158

1.33

4.25

1.3

1.2

u/ml

7.8

13.7

0.93

101

817

(46235355) HIV 1 and 2 tests - Meaningful Use set

217

1646

1.36

4.20

1.7

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

173

2.10

4.18

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

111

745

1.52

4.16

1.2

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

459

1.66

4.13

3.8

2.5

u/ml

0.3

0.4

0.56

259

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

545

1.61

4.13

2.6

1.9

ug/l

7.7

1.6

0.65

471

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

117

797

1.50

4.09

3.1

3.2

pmol/l

4.4

4.5

0.43

106

697

(3019309) Folate [Moles/volume] in Red Blood Cells

349

2849

1.28

4.02

1.8

nmol/l

1106.4

1197.4

1.04

269

2087

(3038177) Helicobacter pylori Ab [Presence] in Serum

176

2.07

4.01

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

290

1.82

3.97

1.2

1.4

—

(4306422)

157

2.12

3.95

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

421

3523

1.26

3.94

1.7

1.6

nmol/l

21.3

21.0

0.15

374

2965

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.65

3.90

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

212

1622

1.35

3.89

2.4

1.9

1.8

0.31

191

1417

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1332

12583

1.26

3.88

6.9

5.8

mmol/mol

40.7

40.0

1.91

1232

11489

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.62

3.81

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

114

2.30

3.79

3.1

5.1

u/ml

162.4

55.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

102

2.37

3.74

1.0

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

2.58

3.72

1.2

u/l

64.6

15.3

0.77

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

289

1.79

3.72

1.2

1.3

—

(3007461) Platelets [#/volume] in Blood

1542

14871

1.36

3.69

31.0

21.3

e9/l

252.7

249.8

0.92

1505

14430

(3024731) MCV [Entitic volume]

1542

14874

1.36

3.66

30.9

21.2

91.2

91.4

1.10

1521

14599

(3035941) MCH [Entitic mass]

1542

14876

1.36

3.64

30.9

21.1

30.3

30.4

0.55

1521

14600

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.55

3.63

1.2

u/l

112.5

70.3

1.11

(3026361) Erythrocytes [#/volume] in Blood

1542

14877

1.36

3.63

31.0

21.2

e12/l

4.4

0.40

1498

14385

(3049717) Cytology report of Urine Cyto stain

540

1.56

3.61

2.4

2.7

—

(3010813) Leukocytes [#/volume] in Blood

1542

14880

1.36

3.59

31.1

21.3

e9/l

7.0

6.7

3.24

1502

14394

(3000963) Hemoglobin [Mass/volume] in Blood

1542

14881

1.36

3.58

31.2

21.4

g/l

133.4

0.02

1518

14609

(3017181) Myelocytes/100 leukocytes in Blood

149

1093

1.40

3.56

4.6

4.0

1.0

0.01

308

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1388

13224

1.26

3.46

5.3

4.7

mmol/l

6.1

6.0

2.88

1269

11879

(3030905) Polymorphonuclear cells [#/volume] in Blood

259

1.80

3.45

3.3

3.0

e9/l

3.5

4.4

3.64

259

(3051651) Icteric interference index of Serum or Plasma

2.46

3.38

3.4

3.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

175

1331

1.35

3.35

1.8

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.26

3.34

1.3

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

162

1.99

3.30

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

157

1.99

3.20

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

110

2.20

3.19

1.0

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

158

1.98

3.15

3.1

3.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

267

1.74

3.14

3.8

3.4

54.3

58.3

2.06

267

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

2.39

3.06

2.6

2.2

ug/min

12.0

64.1

—

(40768443) Skin Pathology biopsy report

595

1.49

3.05

1.3

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

100

2.22

3.00

1.5

u/ml

31.4

20.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

340

1.64

3.00

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

342

2878

1.24

2.99

3.2

3.0

mmol/l

2.5

1.49

272

2531

(3042517) Benzodiazepines panel - Urine

10.02

2.98

1.2

1.0

—

(3037756) Immunofixation for Serum or Plasma

288

1.69

2.93

1.3

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

2.26

2.87

1.5

umol/l

13.8

13.6

0.05

(3024928) Oxygen saturation in Venous blood

284

1.67

2.81

3.7

2.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.24

2.77

1.1

—

(3013512) EKG study

470

4113

1.20

2.74

4.6

4.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

357

1.59

2.72

1.1

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

154

1.90

2.66

1.4

pmol/l

331.0

292.5

0.21

123

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

229

1.72

2.60

1.5

1.2

u/ml

90.3

35.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

363

3116

1.21

2.60

1.8

1.7

pmol/l

70370798.8

22390277.5

0.47

297

2519

(3021440) Promyelocytes/100 leukocytes in Blood

136

1040

1.33

2.56

4.8

4.0

0.1

0.05

280

(3043410) Blood group antigens tested for on Red Blood Cells

2.74

2.55

1.8

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

316

1.60

2.54

1.5

1.2

u/ml

1.5

9.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.51

2.53

4.1

3.2

—

(3032057) Clostridioides difficile [Presence] in Stool

3.04

2.52

2.2

2.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.04

2.52

1.1

1.3

ug/l

9.8

9.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

679

1.41

2.52

2.7

2.5

e6/l

0.3

0.06

661

(3002179) Metamyelocytes/100 leukocytes in Blood

131

1003

1.33

2.46

4.3

3.9

0.7

0.6

0.35

228

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

367

1.54

2.45

1.3

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.47

2.45

1.1

1.2

—

(3017704) Immunofixation for Urine

2.25

2.44

1.3

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

409

3570

1.19

2.43

4.9

5.2

ug/l

2.3

3.3

1.69

362

3146

(3015235) Bicarbonate [Moles/volume] in Capillary blood

320

1.58

2.42

4.2

3.2

mmol/l

24.3

25.1

0.80

282

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

219

1.70

2.42

1.4

1.3

—

(4268621)

110

2.01

2.41

2.6

2.3

—

(3010421) pH of Blood

361

1.54

2.40

6.0

3.4

7.4

0.08

294

(3012501) Base excess in Blood by calculation

298

1.59

2.37

5.9

3.6

mmol/l

3.0

2.7

0.25

211

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.65

2.36

1.8

3.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.65

2.36

1.0

1.4

ng/l

108.8

78.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.65

2.36

1.1

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.51

2.36

1.1

—

16.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

612

1.41

2.34

1.4

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.32

2.31

2.6

1.9

u/field

1.1

2.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

316

1.57

2.31

4.6

3.6

mg/l

23.1

26.6

0.26

197

(3025159) Blasts/100 leukocytes in Blood

128

987

1.32

2.30

5.0

4.1

0.3

0.4

0.19

244

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

398

1.50

2.28

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

127

1.90

2.26

1.3

1.4

nmol/l

0.2

0.3

1.04

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

144

1134

1.29

2.23

3.8

3.6

ng/l

95.5

90.4

0.25

128

968

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.63

2.18

1.2

1.0

92.6

93.7

0.06

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

182

1480

1.26

2.18

3.7

3.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

504

1.43

2.14

2.6

2.3

ug/l

558.3

859.6

0.30

467

(1761482) Bacteria [#/volume] in Urine by Culture

355

1.51

2.14

5.9

4.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.91

2.07

1.1

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.01

2.07

1.0

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

110

1.92

2.06

1.3

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

110

1.92

2.06

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.33

2.05

1.1

ratio

1.1

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

169

1.73

2.04

1.3

1.2

u/ml

2.8

6.2

1.08

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

192

1.68

2.04

2.0

2.1

u/l

10805.0

2905.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

327

2846

1.18

2.00

4.4

4.5

21.9

21.5

0.19

156

1426

(3000475) Leukocytes [#/volume] in Synovial fluid

329

1.50

1.97

1.5

1.7

e6/l

10766.0

14807.0

0.46

241

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1320

12718

1.16

1.92

4.4

4.0

mmol/l

1.3

4.04

1214

11408

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

106

820

1.31

1.90

4.6

3.8

kpa

5.2

0.17

768

(3000330) Specific gravity of Urine by Test strip

715

1.33

1.90

4.3

3.6

—

(3022621) pH of Urine by Test strip

119

936

1.29

1.89

2.9

3.2

—

(3009343) pH of Capillary blood

105

812

1.31

1.89

4.6

3.8

7.4

0.17

118

(3019230) Fractional oxyhemoglobin in Venous blood

236

1.58

1.88

3.9

1.9

64.7

63.4

0.12

236

(1002224) Polysomnography panel

443

1.41

1.84

1.1

—

(3020891) Body temperature

563

1.37

1.83

5.1

3.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

572

1.36

1.82

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

572

1.36

1.82

2.5

g/l

7.1

7.4

1.04

435

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

572

1.36

1.82

2.5

g/l

3.8

3.7

0.25

412

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

4.18

1.82

1.0

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

538

1.37

1.82

2.6

2.5

g/l

2.9

3.2

1.40

419

(3009214) Lutropin [Units/volume] in Serum or Plasma

223

1.58

1.80

1.3

1.2

u/l

12.2

10.5

0.35

171

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

255

1.54

1.79

4.1

2.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

169

1.67

1.77

1.2

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

169

1.67

1.77

1.2

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.90

1.75

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.94

1.75

1.2

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.94

1.75

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

170

1.66

1.74

1.3

1.2

u/ml

3.2

3.6

0.07

(40761536) Microorganisms panel - Urine sediment

138

1119

1.25

1.74

5.6

4.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

500

1.37

1.73

3.1

2.6

g/l

1.3

1.2

0.04

434

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

323

1.47

1.73

1.0

1.1

u/ml

5.0

5.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.85

1.71

1.8

3.5

u/field

0.4

0.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.85

1.71

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

210

1.58

1.71

1.2

1.3

—

(3021788) Differential panel - Synovial fluid

250

1.53

1.71

1.4

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

382

1.43

1.71

1.8

1.5

iu/ml

0.6

14.2

0.48

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

171

1.65

1.71

1.1

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

171

1.65

1.71

1.2

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

133

1.74

1.70

1.5

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

392

1.42

1.68

2.0

1.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

172

1.64

1.67

3.0

2.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

276

1.50

1.67

1.2

miu/ml

174.2

241.6

0.84

114

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

435

1.39

1.67

2.7

2.5

g/l

0.0

0.97

397

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

496

1.37

1.65

2.1

2.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

1.94

1.64

1.3

1.1

mg/l

56.7

34.6

0.37

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.94

1.64

2.0

1.5

g/l

0.9

1.0

1.07

(3023520) Reticulocytes [#/volume] in Blood

148

1221

1.23

1.61

2.3

2.5

e9/l

75.7

68.5

0.98

109

933

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

174

1.62

1.61

1.2

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

312

1.45

1.60

3.5

2.3

g/l

123.3

128.8

1.11

221

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.07

1.60

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

2.51

1.59

1.5

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

780

1.29

1.59

4.8

3.8

mmol/l

1.7

1.9

0.21

603

(21494755) Public health laboratory ask at order entry panel

888

0.74

1.59

1.2

1.4

—

(4198724)

2.70

1.58

2.3

1.3

—

(3021901) Oxygen saturation in Capillary blood

231

1.53

1.57

5.2

3.0

—

(3017732) Neutrophils [#/volume] in Blood

110

880

1.27

1.57

2.8

2.7

e9/l

4.0

0.01

658

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

114

1.76

1.56

2.4

2.3

u/field

5.4

2.1

—

(3028707) Methadone [Presence] in Urine by Screen method

107

1.78

1.55

2.3

1.6

—

(3044941) Cell count panel - Synovial fluid

216

1.54

1.4

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

290

1.46

1.53

1.3

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

406

3665

1.14

1.53

1.8

1.6

mmol/l

1.5

1.3

2.22

353

3052

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

529

1.34

1.53

2.6

g/l

10.3

10.2

0.03

449

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.84

1.51

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.86

1.50

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

162

1.61

1.49

1.5

1.1

u/ml

7.4

2.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

101

1.79

1.49

1.1

1.0

u/ml

0.3

4.0

—

(3023419) Bacteria identified in Sputum by Culture

186

1.57

1.49

3.4

2.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.85

1.46

1.3

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

132

1091

1.23

1.44

2.8

ml/min/173m2

61.9

62.6

0.06

452

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.31

1.43

1.1

—

(3003694) ABO and Rh group [Type] in Blood

379

3425

1.14

1.41

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

173

1.57

1.40

1.2

1.5

—

(3045414) Leukocytes [Presence] in Urine

634

1.29

1.40

2.1

2.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

390

1.37

1.39

1.9

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

305

1.42

1.39

1.8

1.4

—

(3045424) Erythrocytes [Presence] in Urine

223

1.49

1.36

1.6

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

664

1.28

1.35

1.9

1.7

g/l

1.3

1.5

1.22

577

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

112

1.70

1.35

1.3

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

350

1.38

1.34

3.9

3.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

316

1.40

1.34

1.6

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.92

1.33

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.92

1.33

1.2

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

208

1.50

1.33

3.8

3.5

0.7

1.4

1.35

160

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.04

1.33

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

144

1.61

1.32

1.2

1.0

u/ml

4.0

5.8

0.30

(3040151) Glucose [Moles/volume] in Capillary blood

144

1.61

1.32

6.7

4.6

mmol/l

8.5

7.1

0.61

122

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1.85

1.30

1.2

mmol/l

9.6

10.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.36

1.29

3.5

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.36

1.29

3.5

2.9

—

(40768446) Kidney Pathology biopsy report

2.36

1.29

1.8

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.36

1.29

1.1

1.3

—

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

545

1.30

1.28

1.7

1.9

u/l

38.2

39.7

0.25

475

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

789

1.24

1.25

1.3

au/ml

33.0

50.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

234

2065

1.15

1.24

3.1

3.2

ug/l

0.7

0.8

1.33

159

1393

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.86

1.24

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.64

1.21

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

106

874

1.23

1.21

2.4

au/ml

16.3

28.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

693

1.25

1.21

2.4

2.1

nmol/l

12.6

12.5

0.01

604

(3025130) Human papilloma virus identified in Specimen

124

1.62

1.21

1.3

1.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

156

1.55

1.20

1.0

u/ml

2.0

1.8

0.06

(3008401) Mugwort IgE Ab [Units/volume] in Serum

140

1.58

1.20

1.2

1.1

u/ml

0.3

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

197

1.48

1.19

1.2

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.31

1.18

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

181

1.50

1.18

2.5

1.5

—

(3034426) Prothrombin time (PT)

2.11

1.18

1.6

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.11

1.18

1.0

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

137

1163

1.19

1.17

4.7

3.5

mmol/l

1.2

0.02

121

985

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

464

1.30

1.17

3.2

3.4

ratio

1.3

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

457

1.30

1.14

2.7

2.4

g/l

38.1

37.3

0.46

391

(44790047)

150

1.54

1.14

1.7

1.5

—

(44806118)

150

1.54

1.14

1.7

1.5

—

(44790048)

150

1.54

1.14

1.7

1.5

—

(44790049)

150

1.54

1.14

1.7

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

476

1.29

1.12

3.5

3.4

mg/l

37.1

166.0

0.57

390

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

100

829

1.22

1.11

1.4

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

478

1.29

1.09

3.5

3.4

mg/l

34.0

43.3

0.46

393

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.38

1.09

1.2

1.0

—

(40761535) Cells panel - Urine sediment

142

1219

1.18

1.09

5.0

3.5

—

(3037121) Protein [Mass/volume] in Urine

480

1.28

1.07

3.0

3.3

g/l

0.2

0.3

0.85

175

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.76

1.06

1.8

1.7

—

(3015183) Erythrocyte sedimentation rate

1.93

1.06

1.8

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

410

1.30

1.05

2.8

2.6

g/l

0.0

0.00

375

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.13

1.05

1.7

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.67

1.04

2.7

2.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.28

1.03

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1390

13603

1.11

1.01

5.7

5.1

mmol/l

2.6

2.7

7.67

1283

12343

(40767503) Oxygen content in Capillary blood by calculation

300

1.34

0.99

4.5

2.5

14.8

15.9

0.98

152

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

156

1.48

0.98

1.1

—

(3012565) Volume of 24 hour Urine

1.81

0.98

2.0

2.9

1762.7

1880.6

0.12

(3011288) Drugs identified in Urine by Screen method

173

1.45

0.97

2.0

1.8

—

(4035726)

144

1251

1.16

0.97

1.5

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.95

0.97

1.9

1.3

umol/l

2.1

2.2

—

(3011648) Oxygen content in Venous blood

108

1.58

0.96

2.4

1.6

9.3

11.1

0.87

108

(3008757) Leukocyte morphology finding [Identifier] in Blood

149

1.48

0.95

4.0

3.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.69

0.95

1.1

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

242

1.37

0.95

1.4

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

125

1.53

0.94

1.3

1.2

—

32.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

374

1.29

0.93

2.0

1.8

—

(3035880) pH of Pleural fluid

1.67

0.91

1.4

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

159

1.45

0.91

1.3

1.6

69.7

62.4

0.33

101

(3032773) Endomysium IgG Ab [Titer] in Serum

102

1.57

0.90

1.1

—

(3044927) Protein electrophoresis panel - Urine

152

1.45

0.88

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

111

1.54

0.87

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1346

13185

1.10

0.85

5.0

4.5

mmol/l

1.4

1.5

10.63

1243

11943

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.94

0.84

10.0

8.5

58.8

70.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1356

13291

1.10

0.84

5.0

4.5

mmol/l

4.5

4.7

9.94

1260

12107

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

248

1.34

0.84

1.7

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.74

0.82

1.0

1.2

—

(3020650) Glucose [Presence] in Urine

1.88

0.82

1.8

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.61

0.81

1.0

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.61

0.81

1.0

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

189

1.38

0.81

1.8

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

329

1.28

0.81

1.8

1.6

—

(3008898) HLA-B27 [Presence]

356

1.27

0.80

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

321

1.28

0.79

1.9

1.8

iu/l

3.2

5.1

1.03

101

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

216

1.35

0.79

1.6

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.63

0.78

3.3

2.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.59

0.78

4.6

6.4

—

(3044290) Cell count panel - Cerebral spinal fluid

244

1.32

0.75

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

406

1.24

0.73

3.0

2.6

g/l

0.0

0.00

374

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.85

0.73

1.3

1.0

miu/ml

1309.0

1540.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

290

1.28

0.72

2.5

2.4

ug/min

153.3

77.2

0.56

174

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

125

1.44

0.72

1.3

1.4

20.4

31.8

0.63

(3048879) Bone marrow aspiration report

1.80

0.72

1.3

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

308

1.27

0.72

1.4

1.2

mg/l

437.2

545.0

1.80

291

(21491868) Cryoglobulin [Mass/volume] in Serum

1.61

0.72

1.2

1.3

g/l

—

0.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.58

0.71

1.9

2.0

—

(40768795) Lymph node Pathology biopsy report

134

1.42

0.71

1.0

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

229

1.32

0.71

1.9

1.7

nmol/l

37.6

42.2

0.64

218

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.75

0.71

1.4

1.9

pmol/l

14.2

15.3

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.75

0.71

1.7

1.2

mmol/l

3.7

2.9

—

(3006462) Nitrate [Presence] in Urine

1.55

0.69

4.9

3.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.67

0.68

1.0

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.53

0.68

1.1

1.2

—

75.9

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.53

0.68

1.2

2.6

u/ml

982.8

920.8

—

(3014051) Protein [Presence] in Urine by Test strip

347

1.25

0.68

2.3

2.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

102

1.47

0.67

1.9

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.79

0.66

1.4

1.3

—

(3022313) Gas panel - Capillary blood

587

1.18

0.66

4.5

3.8

—

(1761868) Lipid panel - Serum or Plasma

407

4305

0.93

0.65

3.5

2.9

—

(3004451) EKG impression Narrative

1.62

0.65

1.8

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.62

0.65

3.3

4.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

103

1.46

0.65

1.5

1.0

u/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

841

1.15

0.64

1.2

iu/ml

98.9

148.8

1.22

311

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

341

1.24

0.64

1.8

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

1.55

0.62

1.6

2.1

e9/l

0.3

0.2

0.55

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

1.64

0.62

1.0

1.1

—

706.6

—

(21494434) Karyotype in Bone marrow

130

1.39

0.61

1.1

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.48

0.60

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.48

0.60

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.48

0.60

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

165

1.34

0.60

1.6

1.3

e6/l

21395.3

109552.7

1.25

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

(40768806) Pleura Pathology biopsy report

157

1.34

0.59

1.7

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.57

0.58

1.1

1.6

ug/l

3.1

2.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.46

0.58

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.46

0.58

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.46

0.58

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

923

0.87

0.57

2.1

1.8

—

(44806420)

1.62

0.55

2.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

133

1.36

0.55

1.6

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

221

2053

1.09

0.55

1.5

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

142

1.34

0.54

1.7

2.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

151

1.33

0.54

2.0

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

160

1.32

0.53

4.4

3.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

313

1.22

0.53

1.5

1.3

—

(3011412) CD3 cells [#/volume] in Blood

108

1.39

0.53

3.0

2.1

e9/l

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

396

1.19

0.53

1.2

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

268

1.24

0.52

1.5

1.3

e6/l

21.3

38.6

0.26

214

(4027681)

1.52

0.52

1.6

1.1

—

(3017569) Oxygen content in Arterial blood

1.52

0.52

1.8

3.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.43

0.52

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.43

0.52

2.1

1.3

—

(3016750) Collection duration of Urine

1.41

0.51

2.9

2.3

min

510.4

495.3

—

(4211845)

1.41

0.51

4.9

3.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.50

0.49

1.4

2.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.47

0.47

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

164

1.28

0.46

1.3

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

430

1.17

0.46

1.2

1.3

iu/l

33.8

31.3

0.21

362

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

129

1.32

0.45

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.43

0.45

1.8

1.6

—

67.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

183

1.26

0.45

1.6

1.3

e6/l

1880.2

1678.7

0.16

133

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.37

0.44

3.7

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

735

1.12

0.43

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

202

1.24

0.43

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

194

1.24

0.42

1.6

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.41

0.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.36

0.41

1.5

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.36

0.41

1.5

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.33

0.40

1.5

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

1.43

0.39

1.0

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

820

1.10

0.37

1.8

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

125

1.28

0.37

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.29

0.36

1.3

1.4

ug/l

6.9

9.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

198

1.22

0.36

2.1

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1.36

0.36

2.6

1.5

nmol/l

17.0

18.6

0.31

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.32

0.35

1.5

1.1

u/l

9.6

12.4

0.48

(3016879) Cocaine [Presence] in Urine

245

1.19

0.35

1.9

1.5

—

(3024263) Appearance of Synovial fluid

1.37

0.34

1.7

1.6

—

(44813793)

1.32

0.33

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.33

0.33

1.3

1.2

69.6

54.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

127

1.26

0.33

1.7

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

109

1.29

0.33

1.2

1.1

—

40.8

—

(3033799) Differential panel - Peritoneal fluid

1.31

0.33

1.5

2.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.31

0.33

2.0

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.28

0.32

1.0

1.4

—

(40765096) Chromosome analysis panel by Banding

1.28

0.32

1.2

1.1

—

(4015189)

1.28

0.32

1.5

2.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

418

1.13

0.31

1.7

mg/l

6.1

3.0

0.68

298

(3023410) Appearance of Cerebral spinal fluid

120

1.25

0.30

1.6

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1.31

0.30

3.2

1.9

11.3

12.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

306

1.15

0.30

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

166

1.21

0.30

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.23

0.29

1.4

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

517

1.11

0.28

2.1

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

355

1.13

0.28

3.1

nmol/l

0.9

0.8

0.50

267

(3047189) Immunofixation for 24 hour Urine

1.29

0.28

1.1

1.9

—

(4024509)

149

1.21

0.28

1.6

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.27

0.27

1.3

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

1.25

0.27

1.5

nmol/l

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

159

1.20

0.26

1.9

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.70

0.26

1.0

1.1

—

15.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.68

0.26

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

138

0.80

0.25

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

540

1.10

0.25

1.7

1.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

1.23

0.25

2.8

1.9

—

20.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

123

1.22

0.25

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

123

1.22

0.25

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

123

1.22

0.25

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

246

1.14

0.23

1.9

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

143

1.19

0.23

1.3

e6/l

165975.0

93010.0

—

100

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.28

0.23

5.6

1.8

—

(3014271) Vancomycin [Susceptibility]

1.27

0.22

2.6

2.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.22

0.22

1.2

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.21

0.0

6.8

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.21

0.0

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.21

0.0

4.2

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.21

0.0

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

10.8

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.1

—

14.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.20

0.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

111

0.81

0.20

1.3

1.5

—

(3019225) pH of Specimen

153

1469

1.05

0.19

4.8

4.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

569

1.07

0.19

2.3

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

175

1.14

0.18

1.8

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

110

1.18

0.17

1.2

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.76

0.17

1.2

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

173

1789

0.96

0.16

4.9

4.6

33.6

33.3

0.13

124

1141

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.18

0.16

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

681

1.06

0.16

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.13

0.15

2.3

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.11

0.15

2.3

1.5

—

(3045788) Cell count panel - Pleural fluid

150

1.13

0.14

1.7

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

202

0.89

0.14

1.9

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

343

1.08

0.14

1.8

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

160

1.13

0.14

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

141

1.14

0.14

1.6

1.3

mmol/l

6.3

6.6

0.21

135

(3008295) Osmolality of Serum or Plasma

152

1.12

0.12

1.2

1.3

mosm/kgh2o

288.2

274.7

—

109

(3000764) Benzodiazepines [Presence] in Urine

268

1.08

0.12

2.0

1.5

—

(3027008) Opiates [Presence] in Urine

269

1.08

0.11

2.0

1.5

—

(3027944) Amphetamines [Presence] in Urine

269

1.08

0.11

2.0

1.5

—

(4281824)

178

0.90

0.11

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

153

1.11

0.11

1.4

2.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

153

1.11

0.11

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

153

1.11

0.11

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

115

1.13

0.10

2.4

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.14

0.10

1.4

1.1

—

(3044007) Cell count panel - Peritoneal fluid

1.11

0.09

1.4

2.1

—

(3028300) Cannabinoids [Presence] in Urine

271

1.07

0.09

2.0

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.83

0.08

1.0

1.1

—

(40768793) Breast Pathology biopsy report

379

0.95

0.08

1.2

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.77

0.08

1.4

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

1.04

0.08

1.6

1.3

nmol/l

135.1

141.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.03

0.07

2.0

1.5

—

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.08

0.07

1.5

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.08

0.07

1.5

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.08

0.07

1.5

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.08

0.07

1.5

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.07

0.07

2.4

2.3

—

(3000012) Reticulocyte production index

1.03

0.07

1.1

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

112

0.89

0.07

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.12

0.07

2.0

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

191

0.94

0.04

6.1

4.5

umol/l

345.6

347.4

0.02

163

(4094501)

377

1.04

0.04

1.1

—

(3042631) Mycobacterium sp identified in Specimen

209

1.05

0.04

2.4

2.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

101

1.09

0.04

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

361

0.97

0.03

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

240

1.04

0.03

1.5

1.6

—

(4146454)

161

1.06

0.03

2.6

2.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

161

1.06

0.03

2.4

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

103

1.07

0.02

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

133

1.05

0.01

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

133

1.05

0.01

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

133

1.05

0.01

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

133

1.05

0.01

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

183

1838

1.00

0.01

9.4

7.1

—

(3005033) Fetal Nuchal fold Thickness US

106

0.94

0.01

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

106

0.94

0.01

1.3

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

144

1.04

0.00

1.3

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.05

0.00

2.3

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

145

1.03

0.00

2.5

2.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

111

0.99

0.00

1.4

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

191

0.99

0.00

1.2

1.1

—

12.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

619

1.00

0.00

1.6

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

124

0.97

0.00

2.0

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

134

0.97

0.00

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

166

1.02

0.00

1.1

1.3

—

(4034850)

476

1.01

0.00

12.1

10.7

—

(40768800) Prostate Pathology biopsy report

242

0.99

0.00

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

158

1.01

0.00

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.95

0.00

1.6

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.99

0.00

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.0

1.0

—

(3025315) Body weight

0.00

0.0

4.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

2.1

—

1.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.98

0.00

5.8

1.7

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

2.8

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.88

0.00

1.2

u/l

118.2

82.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

14.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.88

0.00

1.2

u/l

28.3

25.8

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.2

—

376.6

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.0

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.7

—

8.6

—

(3026480) Teichoate Ab [Titer] in Serum

0.00

0.0

1.0

—

(3013466) aPTT in Blood by Coagulation assay

0.00

0.0

1.0

—

33.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.0

6.6

—

11.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

6.3

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.0

1.1

—

93.9

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.90

0.00

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_GALLBLAOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_GALLBLAOTH	1.493 [1.32, 1.69]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.034

During the follow-up period (1.1.1998 — 31.12.2019), 860 out of 3457 females with K11_GALLBLAOTH died.

Males

Parameter	HR [95% CI]	p-value
K11_GALLBLAOTH	1.511 [1.32, 1.74]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.022

During the follow-up period (1.1.1998 — 31.12.2019), 816 out of 2490 males with K11_GALLBLAOTH died.

Mortality risk

Mortality risk for people of age

years, who have K11_GALLBLAOTH.

N-year risk	Females	Males
1	0.177%	0.305%
5	0.953%	1.729%
10	1.97%	4.354%
15	3.672%	8.803%
20	6.419%	14.59%

Relationships between endpoints

↥

Index endpoint: K11_GALLBLAOTH – Other diseases of gallbladder

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other diseases of gallbladder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints